생명과학 애널리틱스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Life Science Analytics Market size is expected to reach USD 31.07 Billion in 2034 from USD 15.53 Billion (2025) growing at a CAGR of 8.01% during 2026-2034.

The global life science analytics market has grown rapidly due to the increasing use of data analytics in pharmaceutical research, healthcare, and biotechnology. Life science analytics involves analyzing complex biological and healthcare data to support decision-making in drug development, clinical trials, and healthcare management. The growing availability of digital health data has significantly expanded the role of analytics in the life sciences sector.

Several drivers are contributing to the growth of this market. Pharmaceutical companies are using advanced analytics to accelerate drug discovery and improve clinical trial efficiency. Healthcare organizations are also adopting data analytics to enhance patient outcomes and optimize treatment strategies. Additionally, the integration of artificial intelligence and machine learning has improved the ability to process large biological datasets.

The future of the life science analytics market looks promising as digital transformation continues across the healthcare industry. Advances in data management technologies and increased investment in research are expected to drive innovation. As organizations rely more heavily on data-driven insights, life science analytics will play a crucial role in shaping the future of healthcare and biotechnology.

MARKET SEGMENTATION

By Component

• Software
• Services

By Type

• Reporting
• Descriptive
• Predictive
• Prescriptive

By Application

• Research And Development
• Sales And Marketing Support
• Regulatory Compliance
• Supply Chain Analytics
• Pharmacovigilance

By Delivery

• On-Demand
• On-Premise

By End Use

• Medical Devices
• Pharmaceutical
• Biotechnology
• Genomics
• Others

COMPANIES PROFILED

• Oracle, IQVIA, SAS Institute Inc, Cognizant, IBM, Accenture, Take Solutions Limited, Wipro Limited, Veradigm, Optum, Veeva Systems, Axtria, Komoda Health Inc, Elsevier
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Reporting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Descriptive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Predictive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Prescriptive Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Research And Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sales And Marketing Support Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Regulatory Compliance Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Supply Chain Analytics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Pharmacovigilance Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY DELIVERY 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Delivery
• 7.2. On-Demand Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. On-Premise Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY END USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End Use
• 8.2. Medical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Pharmaceutical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Component
  • 9.2.2 By Type
  • 9.2.3 By Application
  • 9.2.4 By Delivery
  • 9.2.5 By End Use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Component
  • 9.3.2 By Type
  • 9.3.3 By Application
  • 9.3.4 By Delivery
  • 9.3.5 By End Use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Component
  • 9.4.2 By Type
  • 9.4.3 By Application
  • 9.4.4 By Delivery
  • 9.4.5 By End Use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Component
  • 9.5.2 By Type
  • 9.5.3 By Application
  • 9.5.4 By Delivery
  • 9.5.5 By End Use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Component
  • 9.6.2 By Type
  • 9.6.3 By Application
  • 9.6.4 By Delivery
  • 9.6.5 By End Use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL LIFE SCIENCE ANALYTICS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Oracle
  • 11.2.2 IQVIA
  • 11.2.3 SAS Institute Inc
  • 11.2.4 Cognizant
  • 11.2.5 IBM
  • 11.2.6 Accenture
  • 11.2.7 Take Solutions Limited
  • 11.2.8 Wipro Limited
  • 11.2.9 Veradigm
  • 11.2.10 Optum
  • 11.2.11 Veeva Systems
  • 11.2.12 Axtria
  • 11.2.13 Komoda Health Inc
  • 11.2.14 Elsevier